title: FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin.
abstract: Serotonin is a critical regulator of bone mass, fulfilling different functions depending on its site of synthesis. Brain-derived serotonin promotes osteoblast proliferation, whereas duodenal-derived serotonin suppresses it. To understand the molecular mechanisms of duodenal-derived serotonin action on osteoblasts, we explored its transcriptional mediation in mice. We found that the transcription factor FOXO1 is a crucial determinant of the effects of duodenum-derived serotonin on bone formation We identified two key FOXO1 complexes in osteoblasts, one with the transcription factor cAMP-responsive element-binding protein 1 (CREB) and another with activating transcription factor 4 (ATF4). Under normal levels of circulating serotonin, the proliferative activity of FOXO1 was promoted by a balance between its interaction with CREB and ATF4. However, high circulating serotonin levels prevented the association of FOXO1 with CREB, resulting in suppressed osteoblast proliferation. These observations identify FOXO1 as the molecular node of an intricate transcriptional machinery that confers the signal of duodenal-derived serotonin to inhibit bone formation.
authors.affiliation: Department of Medicine, Division of Endocrinology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
authors.forename: Aruna
authors.initials: A
authors.lastname: Kode
authors.forename: Ioanna
authors.initials: I
authors.lastname: Mosialou
authors.forename: Barbara C
authors.initials: BC
authors.lastname: Silva
authors.forename: Marie-Therese
authors.initials: MT
authors.lastname: Rached
authors.forename: Bin
authors.initials: B
authors.lastname: Zhou
authors.forename: Ji
authors.initials: J
authors.lastname: Wang
authors.forename: Tim M
authors.initials: TM
authors.lastname: Townes
authors.forename: Rene
authors.initials: R
authors.lastname: Hen
authors.forename: Ronald A
authors.initials: RA
authors.lastname: DePinho
authors.forename: X Edward
authors.initials: XE
authors.lastname: Guo
authors.forename: Stavroula
authors.initials: S
authors.lastname: Kousteni
mesh_terms: D051701:Activating Transcription Factor 4 / Q000502:physiology; D000818:Animals; D001812:Blood-Brain Barrier; D016723:Bone Remodeling / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured / Q000187:drug effects; D017362:Cyclic AMP Response Element-Binding Protein / Q000502:physiology; D004386:Duodenum / Q000378:metabolism*; D000071161:Forkhead Box Protein O1; D051858:Forkhead Transcription Factors / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D005786:Gene Expression Regulation; D017930:Genes, Reporter; D005838:Genotype; D006706:Homeostasis / Q000502:physiology; D007334:Insulin-Like Growth Factor I / Q000235:genetics; D060492:Low Density Lipoprotein Receptor-Related Protein-5 / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D020935:MAP Kinase Signaling System / Q000187:drug effects; D051379:Mice; D009928:Organ Specificity; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D010012:Osteogenesis / Q000502:physiology; D011401:Promoter Regions, Genetic; D044302:Receptor, Serotonin, 5-HT1B / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D012701:Serotonin / Q000097:blood / Q000494:pharmacology / Q000502:physiology*; D013312:Stress, Physiological / Q000235:genetics; D014158:Transcription, Genetic
chemical_list: C081452:Atf4 protein, mouse; C492004:Creb1 protein, mouse; D017362:Cyclic AMP Response Element-Binding Protein; D000071161:Forkhead Box Protein O1; D051858:Forkhead Transcription Factors; C467200:Foxo1 protein, mouse; D060492:Low Density Lipoprotein Receptor-Related Protein-5; C555483:Lrp5 protein, mouse; D044302:Receptor, Serotonin, 5-HT1B; C519530:insulin-like growth factor-1, mouse; D051701:Activating Transcription Factor 4; D012701:Serotonin; D007334:Insulin-Like Growth Factor I